Advertisement

Topics

X4 Pharmaceuticals signs agreement to merge with Arsanis subsidiary

19:00 EST 28 Nov 2018 | Pharmaceutical Technology

X4 Pharmaceuticals has signed a definitive agreement to merge with a wholly owned subsidiary of Arsanis in an all-stock transaction....
Read More...

The post X4 Pharmaceuticals signs agreement to merge with Arsanis subsidiary appeared first on Pharmaceutical Technology.

Original Article: X4 Pharmaceuticals signs agreement to merge with Arsanis subsidiary

NEXT ARTICLE

More From BioPortfolio on "X4 Pharmaceuticals signs agreement to merge with Arsanis subsidiary"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...